NGGT-006

N/A

Report date: 2025/09/29 15:33:29

Base Information

Drug NameNGGT-006
Drug Alias NameNGGT-006NGGT006
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionLDLR gene transference
TargetsLDL receptor
Therapy Area/IndicationsHomozygous familial hypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Nuojiebei Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Nuojiebei Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A